# Top 50 Life Science Startup Investors in China in May 2026

## Sequoia Capital China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 5
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Artificial Intelligence

We help founders build enduring companies.

## Hillhouse Capital Group
- Type: VC Fund
- Location: Changyang, Beijing, China
- Relevant deals: 5
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Software

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

## EFung Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

## Huagai Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 4
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## Entrepreneurship Relay Group
- Type: VC Fund
- Location: Yangpu, Hainan, China
- Relevant deals: 3
- Stages: Series A, Angel, Series C
- Focus: Medical, Life Science, Biotechnology

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## Eight Roads Ventures
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Software, Health Care, Information Technology

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

## Loyal Valley Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm with strong entrepreneurial culture that invests in middle market companies positioned to benefit from the secular industry transformations in China. With over US$1.6 billion of assets under management, LVC mainly focuses on the following segments: Consumer (TMT,Internet, and Education), Healthcare, and Advanced Manufacturing. Our investment process is characterized by in-depth top-down and bottom-up fundamental research to uncover secular themes and utilize extensive industry mapping to deploy capital in a high conviction and disciplined approach. We pride ourselves as a trusted influential shareholder relentlessly focused on active value creation and accelerating growth via strategic initiatives through our extensive network of business leaders in China. LVC manages capital on behalf of international institutional investors such as sovereign wealth funds, funds of funds, private banks, and family offices, as well as elite entrepreneurs and founders of China’s Fortune 500 enterprises.LVC was founded in 2015 by Andy Lin, an experienced investor and accomplished entrepreneur. He is the founder of China Universal Asset Management (“CUAM”), one of China’s largest equity investor and asset manager with over US$100B in AUM, known for its industry leading research and award-winning investment records.

## Bits x Bites
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Food and Beverage, Food Processing

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, E-Commerce

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## ULTIMA
- Type: VC Fund
- Location: Chengdu, Sichuan, China
- Relevant deals: 2
- Stages: Angel, Series A
- Focus: Hardware, Software, Agriculture

ULTIMA is an investment management firm.

## CentreGold Capital
- Type: VC Fund
- Location: Fremont, California, United States
- Relevant deals: 2
- Stages: Seed, Series A, Angel
- Focus: Internet, Medical Device, Artificial Intelligence

Our team invests in early-stage digital health and consumer startups at CentreGold Capital. 

## BOHE Angel Fund
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 2
- Stages: Angel, Seed, Series A
- Focus: Health Care, Medical, Biotechnology

BOHE Angel Fund is an investment Fund.

## Orient Securities Capital Investment
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series D, Series C
- Focus: Health Care, Manufacturing, Software

Orient Securities Capital Investment is an private equity fund business platform.

## Lucion
- Type: VC Fund
- Location: Jinan, Shandong, China
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Medical, Manufacturing

Lucion is an influential professional venture capital institute.

## Sherpa Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Green Pine Capital Partners
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Angel, Series B
- Focus: Artificial Intelligence, Manufacturing, Software

Green Pine Capital Partners is a venture capital firm.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## ASBV
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Seed, Angel
- Focus: Health Care, Medical, Biotechnology

ASBV focuses on early and mid-term venture capital investments.

## WuXi AppTec
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Pharmaceutical, Health Care

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

## Huimei Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

## MiraclePlus
- Type: VC Fund
- Location: Haidian, Beijing, China
- Relevant deals: 2
- Stages: Seed, Angel, Pre-Seed
- Focus: Artificial Intelligence, Software, Information Technology

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

## Step Fund
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 1
- Stages: Seed, Series B
- Focus: Biotechnology, Software, Electronics

Step Fund is a chinese venture firm.

## Haitang Fund
- Type: VC Fund
- Location: Nankai, Tianjin, China
- Relevant deals: 1
- Stages: Series A
- Focus: Life Science, Biotechnology, Advanced Materials

Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.

## Ennovation Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 1
- Stages: Seed

Ennovation Ventures is a venture capital firm that focuses on biomedical and medical health.

## Saizhi Bole
- Type: VC Fund
- Relevant deals: 1
- Stages: Series B
- Focus: Software, Manufacturing, Data and Analytics

Saizhi Bole is an investment firm.

## Wanwu Capital
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Artificial Intelligence, Agriculture, SaaS

Wanwu Capital is an investment firm

## Qingdao Qingchi Venture Capital
- Type: VC Fund
- Location: Qingdao, Fujian, China
- Relevant deals: 1
- Stages: Series A
- Focus: Biotechnology, Science and Engineering

Qingdao Qingchi Venture Capital is an investment firm.

## Q Ventures
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 1
- Stages: Series A
- Focus: Biotechnology, Science and Engineering

Qiantang Venture Capital focuses on investment in domestic and overseas early-stage projects.

## SDIC Venture Capital
- Type: VC Fund
- Location: Xicheng, Hebei, China
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Manufacturing, Biotechnology, Health Care

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

## Hubei Tianchi Enterprise Management
- Type: VC Fund
- Location: Hubei, Fujian, China
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Life Science

Hubei Tianchi Enterprise Management is engaged in corporate management services.

## Dynamic Balance Capital
- Type: VC Fund
- Location: Nanjing, Jiangsu, China
- Relevant deals: 1
- Stages: Series A, Angel, Seed
- Focus: Health Care, Manufacturing, Biotechnology

Dynamic Balance Investment is a core subsidiary of Jiangning Technology Venture Capital , it focuses on investments in the biomedical, TMT, clean energy and new material industries.

## Qingdao Holdings International
- Type: VC Fund
- Location: Admiralty, Hong Kong Island, Hong Kong
- Relevant deals: 1
- Stages: Seed
- Focus: AgTech, Genetics, Life Science

Qingdao Holdings International offers property leasing, production and sale of educational equipment, consulting services, real estate development, and loan financing.

## Haoping Investment
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Life Science, Biotechnology

Haoping Investment is an investment firm.

## Zhongke Weilan
- Type: VC Fund
- Location: Haidian, Beijing, China
- Relevant deals: 1

Vulab Tech is an information security firm that provides security a vulnerability management and analysis solution through an AI engine.

## Kunlun Capital
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Medical, Genetics

Kunlun Capital is a value-oriented and fundamentally driven family office. We do not manage external funds.

## China Medical System Holdings Limited
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 1
- Stages: Seed
- Focus: Biotechnology, Medical, Health Care

CMS is a specialty pharmaceutical company based in China, focusing on marketing, promotion and sales of prescription drugs and other medicinal products to all therapeutic departments in hospitals nation-wide. CMS builds up its product portfolio for its target markets by asset acquisition, equity investment, licensing-in and distribution partnershipon the global basis as well as in-house R&D.

## Sunz Fund
- Type: VC Fund
- Location: Changsha, Jiangsu, China
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Medical, Health Care, Biotechnology

Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.

## Anhui High-tech Industry Investment
- Type: VC Fund
- Location: Hefei, Anhui, China
- Relevant deals: 1
- Stages: Angel
- Focus: Medical, Health Care, Life Science

Anhui High-tech Industry Investment is engaged in high-tech industry investment and related derivative business.

## Qiji Zhiguang Fund
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 1
- Stages: Angel
- Focus: Life Science, Biotechnology

Qiji Zhiguang Fund is an investment fund Of BGI.

## Tsing-Yuan Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 1
- Stages: Series A, Angel, Series B
- Focus: Manufacturing, Health Care, E-Commerce

Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.

## Country Garden Venture Capital
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Manufacturing, Biotechnology, Hardware

Country Garden Ventures was established in January 2019. It is a first-level business unit of Country Garden Group. It is responsible for the group's equity investment business in addition to real estate investment.
     Since its establishment, Country Garden Ventures has always adhered to the investment strategy of “industry empowerment andvalue co-creation”, paying equal attention to financial investment and holding investment, and has initially formed a staged, dedicated track, and multi-level investment portfolio. Up to now, the team has accumulatively invested in many star companies such as Shell Search, Qinhuai Data, Ziguang Zhanrui, Penguin Almond, Hobo Pharmaceutical, Blue Arrow Aerospace, Xinruipeng Pet Medical, Lin Qingxuan and so on.

## Starlight Capital
- Type: VC Fund
- Location: Pudong, Shandong, China
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Agriculture, Life Science

Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.

## Cathay Biotech
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Life Science, Biotechnology

Cathay Biotech is a global technology leader in synthetic biology and the use of bio-processes to produce new materials on an industrial scale. Cathay’s long chain diacids are a perfect example demonstrating the potential for renewable bio-manufacturing to commercially displace traditional chemical processes. Cathay also developed and became thefirst commercial producer of pentanediamine from renewable materials. Having the two key monomers to produce polyamides, Cathay also is a global innovator in the commercialization of new and unique renewable polyamides for the engineering polymer and textile markets.
As a game-changing production technology, bio-production starts with biomass and other raw materials for biological conversion to higher value products. The nature of bio-production requires environmentally friendly and mild conditions that are inherently economical. The goal of Cathay’s synthetic biology development programs is to address the excessive dependence of humans on traditionally produced chemicals as well as the subsequent environmental damage and worker safety issues associated with their production.
Cathay’s headquarters and R&D are located within Zhangjiang Hi-Tech park in Shanghai, P.R. China and the two production sites are in Jinxiang, Shandong Province, and Wusu, Xinjiang Province, also in China.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co